Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy. - Malmström,A.; Grønberg,H.; Stupp,R. (J Clin Oncol, 2010)